Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complement activation in diseases presenting with thrombotic microangiopathy.

European journal of internal medicine - 1 Sept 2013

Meri Seppo

Abstract excerpt

The complement system contains a great deal of biological "energy". This is demonstrated by the atypical hemolytic uremic syndrome (aHUS), which is a thrombotic microangiopathy (TMA) characterized by endothelial and blood cell damage and thrombotic vascular occlusions. Kidneys and often also other organs (brain, lungs and gastrointestinal tract) are affected. A principal pathophysiological feature in aHUS is a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atypical Hemolytic Uremic Syndrome
Share to Complement Factor B
Share to Complement Factor I

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Complement Pathway, Alternative

Share to Hemolytic-Uremic Syndrome

Share to Membrane Cofactor Protein

Share to Purpura, Thrombotic Thrombocytopenic

Share to Thrombomodulin

Source

Identifiers

PMID: 23743117
DOI: 10.1016/j.ejim.2013.05.009

Genes

ADAMTS13
DGKE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complement activation in diseases presenting with thrombotic microangiopathy.PMID 23743117Read ↗

Complement Mediated Endothelial Damage in Thrombotic MicroangiopathiesSemantic proximity Read ↗

Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment ApproachesSemantic proximity Read ↗

Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome.Semantic proximity Read ↗

An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus documentSemantic proximity Read ↗

Alternative complement pathway assessment in patients with atypical HUS.Semantic proximity Read ↗

Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.Semantic proximity Read ↗

Pathogenesis and prognosis of thrombotic microangiopathy.Semantic proximity Read ↗

Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panaceaSemantic proximity Read ↗

Complement in hemolytic anemia.Semantic proximity Read ↗

[Atypical HUS caused by complement-related abnormalities].Semantic proximity Read ↗

Advances in understanding of pathogenesis of aHUS and HELLP.Semantic proximity Read ↗

Complement in hemolytic anemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.